MedTrace Logo

Association Between Cancer and Anti-synthetase Syndrome

NCT04941547 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2021-06-28

No results posted yet for this study

Summary

Among Idiopathic inflammatory myopathies, antisynthetase syndrome is meant to be rarely associated with cancer. However, clinical evidences of the association of those diseases led to the hypothesis that previous studies might have underestimated the prevalence of cancer in patients with antisynthetase syndrome. The aim of this study was to assess the prevalence of cancer in patients with antisynthetases syndrome in Grand Est and Bourgogne Franche-Comté regions.

Conditions

  • Antisynthetase Syndrome

Sponsors & Collaborators

  • Centre Hospitalier Universitaire Dijon

    collaborator OTHER

  • CHU de Reims

    collaborator OTHER

  • University Hospital, Strasbourg, France

    collaborator OTHER

  • Hopitaux Prives de Metz, Groupe UNEOS

    collaborator OTHER

  • Centre Hospitalier Universitaire de Besancon

    collaborator OTHER

  • Central Hospital, Nancy, France

    lead OTHER

Principal Investigators

  • Thomas Moulinet, MD · CHRU de Nancy

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-04-01
Primary Completion
2021-07-31
Completion
2021-09-01

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04941547 on ClinicalTrials.gov